Abstract
This study reports 2-year survival outcomes among patients with advanced nonprogressive stage IIA to IV lung cancer randomized to symptom monitoring during chemotherapy via web-based patient-reported outcomes vs standard scheduled imaging after treatment to detect symptomatic recurrence.
Publication types
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Diagnostic Self Evaluation
-
Humans
-
Internet*
-
Kaplan-Meier Estimate
-
Lung Neoplasms / diagnosis
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / mortality*
-
Neoplasm Recurrence, Local / diagnosis
-
Population Surveillance / methods*
-
Self Report*
-
Symptom Assessment / methods*